DDUV
Avenue Hippocrate 74/B1.74.03
1200 Woluwe-Saint-Lambert
- Accueil
- Répertoire
- Jingjing Zhu
Jingjing Zhu
Collaboratrice scientifique
- Diplômes
Année Label Institution 2006 (informations manquantes) Northwest university 2009 Master of Science Northwest university 2013 (informations manquantes) Katholieke Universiteit Leuven
Zhu, Jingjing ; Van den Eynde, Benoit. AHR and tryptophan metabolism: a collaborative dynamics of immune regulation. In: Genes and Immunity, (2023). doi:10.1038/s41435-023-00235-6.
Vermorken, Alphons J M ; Zhu, Jingjing ; Ma, Le ; Cui, Yali. Can niacin supplementation prevent congenital malformations associated with maternal use of proton pump inhibitors?. In: European journal of nutrition, Vol. 62, no.2, p. 1051-1053 (2023). doi:10.1007/s00394-022-03060-1.
Minati, Marie-Albane ; Fages, Angeline (co-first author) ; Dauguet, Nicolas ; Zhu, Jingjing ; Jacquemin, Patrick. Optimized nucleus isolation protocol from frozen mouse tissues for single nucleus RNA sequencing application.. In: Frontiers in cell and developmental biology, Vol. 11, p. 1243863 [1-10] (2023). doi:10.3389/fcell.2023.1243863.
Zhu, Jingjing. Tryptophan depletion sensitizes the AHR pathway by increasing AHR expression and GCN2/LAT1-mediated kynurenine uptake, and potentiates induction of regulatory T lymphocytes. In: bioRxiv, (2023).
Solvay, Marie ; Holfelder, Pauline ; Klaessens, Simon ; Pilotte, Luc ; Stroobant, Vincent ; Lamy, Juliette ; Naulaerts, Stefan ; Spillier, Quentin ; Frédérick, Raphaël ; De Plaen, Etienne ; Sers, Christine ; Opitz, Christiane A ; Van den Eynde, Benoit ; Zhu, Jingjing. Tryptophan depletion sensitizes the AHR pathway by increasing AHR expression and GCN2/LAT1-mediated kynurenine uptake, and potentiates induction of regulatory T lymphocytes. In: Journal for ImmunoTherapy of Cancer, Vol. 11, no. 6, p. e006728 (2023). doi:10.1136/jitc-2023-006728.
Zhu, Jingjing ; Naulaerts, Stefan ; Boudhan, Loubna ; Martin, Manon ; Gatto, Laurent ; Van den Eynde, Benoit. Tumour immune rejection triggered by activation of α2-adrenergic receptors. In: Nature, Vol. 618, no.7965, p. 607-615 (2023). doi:10.1038/s41586-023-06110-8.
Petit, Pierre-Florent ; Bombart, Raphaële ; Desimpel, Pierre-Hubert ; Naulaert, Stefan ; Thouvenel, Laurie ; Collet, Jean-François ; Van den Eynde, Benoît ; Zhu, Jingjing. T-cell mediated targeted delivery of anti-PD-L1 nanobody overcomes poor 1 antibody penetration and improves PD-L1 blocking at the tumor site. In: Cancer immunology research, Vol. 10, no. 6, p. 713-727 (2022). doi:10.1158/2326-6066.CIR-21-0801.
Vermorken, Alphons J.M. ; Zhu, Jingjing ; Holvoet, Paul ; Cui, Yali. The marker of cobalamin deficiency, plasma methylmalonic acid, may help identifying lysosomal iron trapping in patients. Its possible utility for heart failure. In: Redox Biology, Vol. 44, p. 102011 (2021). doi:10.1016/j.redox.2021.102011.
Vermorken, Alphons J M ; Zhu, Jingjing ; Cui, Yali. Letter: does Helicobacter pylori infection limit the health effects of the Mediterranean diet?. In: Alimentary pharmacology & therapeutics, Vol. 52, no.5, p. 935-936 (2020). doi:10.1111/apt.15945.
Zhu, Jingjing ; Petit, Pierre-Florent ; Van den Eynde, Benoît. Apoptosis of tumor-infiltrating T lymphocytes: a new immune checkpoint mechanism. In: Cancer Immunology, Immunotherapy, (2018). doi:10.1007/s00262-018-2269-y (Accepté/Sous presse).
Zhu, Jingjing ; Powis de Tenbossche, Céline G ; Cané, Stefania ; Colau, Didier ; van Baren, Nicolas ; Lurquin, Christophe ; Schmitt-Verhulst, Anne-Marie ; Liljeström, Peter ; Uyttenhove, Catherine ; Van den Eynde, Benoît. Resistance to cancer immunotherapy mediated by apoptosis of tumor-infiltrating lymphocytes.. In: Nature Communications, Vol. 8, p. 1404 (2017). doi:10.1038/s41467-017-00784-1.
Vermorken, Alphons JM ; Zhu, Jingjing ; Andrès, Emmanuel. Obesity and colorectal cancer risk, the role of oxidative stress. In: Gut, . doi:10.1136/gutjnl-2013-305561 (Accepté/Sous presse).
Zhu, Jingjing ; Bultynck, Geert ; Luyten, Tomas ; Parys, Jan B ; Creemers, John WM ; Van de Ven, Wim JM ; Vermorken, Alphons JM. Curcumin affects proprotein convertase activity: elucidation of the molecular and subcellular mechanism. In: Biochimica et Biophysica Acta : international journal of biochemistry and biophysics, Vol. 1833, no.8, p. 1924-1935 (08/2013). doi:10.1016/j.bbamcr.2013.04.002.
Zhu, Jingjing ; Van de Ven, Wim JM ; Verbiest, Thierry ; Koeckelberghs, Guy ; Chen, Chao ; Cui, Yali ; Vermorken, Alphons JM. Polyphenols Can Inhibit Furin In Vitro As A Result of the Reactivity of their Auto-oxidation Products to Proteins. In: Current Medicinal Chemistry, Vol. 20, no.6, p. 840-850 (01/02/2013). doi:10.2174/0929867311320060009.
Zhu, Jingjing ; Van de Ven, Wim JM ; Vermorken, Alphons JM. Polyphenols with indirect proprotein convertase inhibitory activity. In: International Journal of Oncology, Vol. 43, no.3, p. 947-955 (09/2013). doi:10.3892/ijo.2013.2009.
Andrès, Emmanuel ; Serraj, Khalid ; Zhu, Jingjing ; Vermorken, Alphons JM. The pathophysiology of elevated vitamin B12 in clinical practice. In: QJM : an international journal of medicine, Vol. 106, no.6, p. 505-515 (06/2013). doi:10.1093/qjmed/hct051.
Chao, Xu ; Guo, Lili ; Zhang, Zhuoli ; Zhu, Jingjing ; Vermorken, Alphons JM ; Van de Ven, Wim JM ; Chao, Chen ; Cui, Yali. A novel magnetic nanoparticle drug carrier for enhanced cancer chemotherapy. In: PLoS One, Vol. 7, no.10, p. e40388 (08/10/2012). doi:10.1371/journal.pone.0040388.
Vermorken, Alphons JM ; Zhu, Jingjing ; Van de Ven, Wim JM ; Andrès, Emmanuel. Comment on: Monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and curcumin: a randomized, double-blind placebo-controlled crossover 4g study and an open-label 8g extension study.. In: American Journal of Hematology, Vol. 87, no.10, p. E80 (10/2012). doi:10.1002/ajh.23276.
Vermorken, Alphons JM ; Zhu, Jingjing ; Van de Ven, Wim JM ; Andrès, Emmanuel. Curcumin for monoclonal gammopathies. What can we hope for, what should we fear?. In: Critical Reviews in Oncology / Hematology, Vol. 84, no.3, p. 350-360 (12/2012). doi:10.1016/j.critrevonc.2012.04.005.
Zhu, Jingjing ; Declercq, Jeroen ; Roucourt, Bart ; Ghassabeh, Gholamreza H ; Meulemans, Sandra ; Kinne, Jörg ; David, Guido ; Vermorken, Alphons JM ; Van de Ven, Wim JM ; Lindberg, Iris ; Muyldermans, Serge ; Creemers, John WM. Generation and characterization of non-competitive furin-inhibiting nanobodies. In: Biochemical Journal, Vol. 448, no.1, p. 73-82 (15/11/2012). doi:10.1042/BJ20120537.
Zhu, Jingjing ; Declercq, Jeroen ; Creemers, John ; Chen, Chao ; Cui, Yali ; Van de Ven, Wim JM ; Vermorken, Alphons JM. Limitations of inhibitory activities of polyphenols on furin-mediated substrate processing. In: Current Medicinal Chemistry, Vol. 19, no.21, p. 3641-3650 (2012).
Vermorken, Alphons J. M. ; Zhu, Jingjing ; Van de Ven, Wim JM ; Cui, Yali ; Fryns, Jean-Pierre. Curcumin for the prevention of progression in monoclonal gammopathy of undetermined significance: A word of caution. In: Experimental and Therapeutic Medicine, Vol. 1, no.2, p. 265-269 (03/2010). doi:10.3892/etm_00000041.
Vermorken, Alphons JM ; Zhu, Jingjing ; Van de Ven, Wim JM. Is curcumin for monoclonal gammopathy of undetermined significance without risk?. In: Clinical Cancer Research, Vol. 16, no.7, p. 2225 (01/04/2010). doi:10.1158/1078-0432.CCR-10-0218.
Zhu, Jingjing ; Yang, Liu ; Yang, Lei ; Chen, Chao ; Cui, Yali. [Purification of glutathione-S-transferase fusion protein by glutathione coupled magnetic particles]. In: Sheng Wu Gong Cheng Xue Bao, Vol. 25, no.8, p. 1254-1260 (2009).
Zhu, Jingjing ; Vermorken, Alphons JM ; Van de Ven, Wim JM. Proprotein convertases in homeostasis and pathophysiology; perspectives of targeting furin-mediated proprotein processing to affect tumor development involving IGF axis signalling. In: Recent Research Developments in Cancer, Vol.9, 2011. 978-81-7895-536-0.
Bombart, Raphaële ; Zhu, Jingjing ; Van den Eynde, Benoit J.. Uncovering molecular actors of IDO-mediated T cell dysfunction with genome-wide CRISPR/Cas9 knockout screens. Abstracts: AACR Virtual Special Conference: Tumor Immunology and Immunotherapy (du 05/10/2021 au 06/10/2021). In: Cancer Immunology Research, Vol. 10, no.1, p. 2326-6074 (2022). doi:10.1158/2326-6074.tumimm21-p025.
Zhu, Jingjing. Invited Lecture: Local delivery of anti-PD-L1 nanobodies overcomes poor antibody penetration and allows improved blocking of PD-L1 at the tumor site. 5th Annual MarketsandMarkets Next Gen Immuno-Oncology Virtual Congress (du 26/10/2021 au 29/10/2021).
Zhu, Jingjing. Invited Lecture: T-cell mediated targeted delivery of anti-PD-L1 nanobodies overcomes poor antibody penetration and improves PD-L1 blocking at the tumor site. 6th Annual MarketandMarkets Biomarker and Companion Diagnostics Virtual Conference (du 12/10/2021 au 14/10/2021).
Petit, P-F. ; Zhu, Jingjing ; van den Eynde, B.J.. Improving efficacy and reducing toxicity of anti-PD-L1 treatment: T-cells as delivery vehicles for anti-PD-L1 blocking nanobodies. ESMO Immuno-Oncology Vitual Congress 2020 (du 09/12/2020 au 12/12/2020). In: Annals of Oncology, Vol. 31, no.Supplement 7, p. S1425 (2020). doi:10.1016/j.annonc.2020.10.511.
Zhu, Jingjing. Invited Lecture: Deciphering the role of cancer stem cells in tumoral immune resistance in an autochthonous melanoma model. XI Melanoma Workshop 2019 (Otranto, Italy, du 16/05/2019 au 17/05/2019).
Zhu, Jingjing. Invited Lecture: Tumoral immune resistance based on apoptosis of tumor-infiltrating T cells in an inducible mouse melanoma model. Departmental Research Seminar (Dept. Pharmaceutical Chemistry, Peking Union Medical College, du 25/10/2019 au 25/10/2019).
Zhu, Jingjing. Invited Lecture: Understanding the tumor immune escape and the immune modulatory function of cancer stem cells. 17th International Congress of Immunology (Beijing, China, du 19/10/2019 au 23/10/2019).
Petit, Pierre-Florent ; Zhu, Jingjing ; Van den Eynde, Benoit. T cells secreting nanobody-based immune checkpoint inhibitors. CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference (Paris, France, du 25/09/2019 au 28/09/2019).
Krendyukov, A. ; Kneisel, N. ; Zhu, Jingjing ; Merz, C. ; Richards, D. ; Gieffers, C. ; van den Eynde, B.. The Role of Asunercept as a Selective CD95L Inhibitor in Cutaneous Melanoma: Rationale and Results from an Enhanced TiRP Model. ESMO Immuno-Oncology Congress 2019 (Geneva, Switzerland, du 11/12/2019 au 14/12/2019). In: Annals of Oncology, Vol. 30, no.S11, p. xi43-xi44 (2019). doi:10.1093/annonc/mdz451.026.
Zhu, Jingjing ; Colau, Didier ; Boudhan, Loubna ; Van den Eynde, Benoit. Understanding the tumor immune escape and the immune modulatory function of cancer stem cells. 17th International Congress of Immunology (Beijing, China, du 19/10/2019 au 23/10/2019). In: European Journal of Immunology, Vol. 49, no.Supplement S3, p. 1243 (2019). doi:10.1002/eji.201970400.
Zhu, Jingjing. Invited Lecture: Discovery of novel immuno-oncology targets. Departmental Research Seminar (National Engineering Center for Miniaturized Detection System, Northwest University, du 17/10/2017 au 17/10/2017).
Zhu, Jingjing ; Céline G. Powis de Tenbossche ; Stefania Cané ; Didier Colau ; Van den Eynde, Benoit. Resistance to cancer immunotherapy mediated by apoptosis of tumor-infiltrating lymphocytes. Ludwig Oxford 10th Anniversary Symposium (Oxford, United Kingdom, du 11/09/2017 au 12/09/2017).
Zhu, Jingjing ; Céline G. Powis de Tenbossche ; Stefania Cané ; Didier Colau ; Van den Eynde, Benoit. Resistance to cancer immunotherapy mediated by apoptosis of tumor-infiltrating lymphocytes. Third CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference (Mainz/Frankfurt, Germany, du 06/09/2017 au 09/09/2017).
Declercq, Jeroen ; Zhu, Jingjing ; Lindberg, Iris ; Ghassabeh, Gholamreza H. ; Meulemans, Sandra ; Vermorken, Alphons J.M. ; Van de Ven, Wim J.M. ; Muyldermans, Serge ; Creemers, John W.M.. Generation and characterization of non-competitive furin-inhibiting nanobodies. Proceedings: AACR 103rd Annual Meeting 2012 (Chicago, United States, du 31/03/2012 au 04/04/2012). In: Experimental and Molecular Therapeutics, Vol. 72, no.8, p. 1538-7445 (2012). doi:10.1158/1538-7445.am2012-4627.
Declercq, Jeroen ; Zhu, Jingjing ; Roucourt, Bart ; Ghassabeh, Gholamreza ; Meulemans, Sandra ; Kinne, Jörg ; David, Guido ; Vermorken, Alphons ; Van de Ven, Wim ; Lindberg, Iris ; Muyldermans, Serge ; Creemers, John. Generation and characterization of non-competitive furin-inhibiting nanobodies. Tenth Gordon conference (Colby-Sawyer College New London, NH, USA, du 15/07/2012 au 20/07/2012).
Declercq, Jeroen ; Zhu, Jingjing ; Lindberg, Iris ; Ghassabeh, Gholamreza ; Meulemans, Sandra ; Vermorken, Alphons ; Van de Ven, Wim ; Muyldermans, Serge ; Creemers, John. Generation and characterization of non-competitive furin-inhibiting nanobodies. AACR Annual Meeting (Chicago, USA, du 31/03/2012 au 04/04/2012).
Zhu, Jingjing ; Declercq, Jeroen ; Willekens, Karen ; Creemers, John ; Vermorken, Alphons ; Van de Ven, Willem. Interference of the polyphenolic compound curcumin with expression regulation of target genes of the PLAG1 oncogenic transcription factor. AACR Annual Meeting (Chicago, USA, du 31/03/2012 au 4/04/2012). In: Cancer Research Journal, Vol. 72, no. 8. doi:10.1158/1538-7445.AM2012-4627 Published April 2012.
Zhu, Jingjing ; Vermorken, Alphons ; Van de Ven, Wim. Are proprotein convertases therapeutic targets for prevention of malignant progression of MGUS?. The 3rd Annual Protein and Peptide Conference (Beijing, P.R. China, du 21/03/2010 au 23/03/2010).
Zhu, Jingjing. Inhibition of Proprotein convertase Furin as a target for cancer therapy. Invited Lecture (National Engineering Center for Miniaturized Detection System, Northwest University, 25/03/2010).
Zhu, Jingjing. Invited Lecture: Inhibition of Proprotein convertase Furin as a target for cancer therapy. Departmental Research Seminar (National Engineering Center for Miniaturized Detection System, Northwest University, 25/03/2010).
Zhu, Jingjing ; Van de Ven, Wim ; Verbiest , Thierry ; Vermorken, Alphons. Is the main green tea component epigallocatechin gallate a genuine inhibitor of the proprotein convertase furin?. 8th Annual Congress of International Drug Discovery Science and Technology (Beijing, P.R. China, du 22/10/2010 au 26/10/2010).
Zhu, Jingjing ; Cui, Yali ; Vermorken, Alphons ; Van de Ven, Wim. Optimization of an in-vitro processing assay for the proprotein convertase furin. The 3rd Annual Protein and Peptide Conference (Beijing, P.R. China, du 21/03/2010 au 23/03/2010).
Vermorken, Alphons ; Zhu, Jingjing ; Van de Ven, Wim. Proprotein convertases are therapeutic targets for prevention of malignant progression of MGUS?. The 3rd Annual Protein and Peptide Conference (Beijing, P.R. China, du 21/03/2010 au 23/03/2010).
Zhu, Jingjing ; Van den Eynde, Benoit. ALPHA-2 ADRENERGIC RECEPTOR AGONISTS FOR THE PREVENTION AND/OR THE TREATMENT OF SPLEEN DISORDERS. .
Zhu, Jingjing ; Van den Eynde, Benoit. ALPHA-2 ADRENERGIC RECEPTOR AGONISTS FOR THE TREATMENT OF CANCER. .
Zhu, Jingjing ; Van den Eynde, Benoit. GUANABENZ AS AN ADJUVANT FOR IMMUNOTHERAPY . .